Telmisartan, an FDA-approved blood pressure drug, could boost a certain cancer treatment's effectiveness against tumors, a ...

In A Nutshell A common blood pressure drug, telmisartan, boosted the effectiveness of a cancer drug in lab and mouse studies.

Kardigan’s tonlamarsen reduced a key biomarker for hypertension in a phase 2 trial, but missed the study’s other goal of significantly reducing blood pressure. The biotech evaluated monthly 90 mg ...

While tonlamarsen missed one of two co-primary endpoints, Kardigan says the drug has shown a clinically meaningful effect on blood pressure, supporting advancement into Phase 2b.

In a phase 2 trial of a novel antihypertensive agent, multiple doses lowered plasma angiotensinogen to a greater extent than a single dose, but did not provide further blood pressure lowering, ...

Patients who start their blood pressure treatment with angiotensin receptor blocker (ARB) drugs continue with the same medicine to a greater extent than patients who start out with other drugs.

The investigational drug tonlamarsen—which is designed to lower blood pressure by reducing the production of angiotensinogen, ...

Add Yahoo as a preferred source to see more of our stories on Google. Over half a million bottles of prazosin hydrochloride capsules, a blood pressure medication, are being recalled over a ...

In a new Dartmouth Cancer Center (DCC) study led by clinical researcher Tyler J. Curiel, MD, MPH, FACP, investigators found ...

High blood pressure raises risk of heart attack and stroke. Learn three ways to manage it—DASH diet foods that help, ...

Healthcare providers are urging the Nigerian government to provide free BP drugs, as rising costs worsen the hypertension ...